CTI BioPharma Corp.
CTIC · NASDAQ
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$92,992 | -$97,908 | -$52,451 | -$40,023 |
| Dep. & Amort. | $1,951 | $526 | $532 | $546 |
| Deferred Tax | $0 | $0 | $4,200 | -$1,332 |
| Stock-Based Comp. | $10,030 | $4,743 | $4,317 | $5,166 |
| Change in WC | -$7,919 | $7,863 | -$2,422 | $7,762 |
| Other Non-Cash | $7,736 | -$113 | $3,619 | $59 |
| Operating Cash Flow | -$81,194 | -$84,889 | -$42,205 | -$27,822 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$25,000 | $0 | -$17 | $0 |
| Net Acquisitions | $25,000 | $0 | $0 | $0 |
| Inv. Purchases | -$88,853 | $0 | -$12,100 | -$11,018 |
| Inv. Sales/Matur. | $40,000 | $12,000 | $2,500 | $39,150 |
| Other Inv. Act. | -$25,000 | $0 | $0 | $0 |
| Investing Cash Flow | -$73,853 | $12,000 | -$9,617 | $28,132 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $56,943 | $59,064 | $66,265 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $120,021 | $97,941 | $61,072 | -$5,607 |
| Financing Cash Flow | $120,021 | $97,941 | $61,072 | -$5,607 |
| Forex Effect | $0 | $0 | $0 | $2 |
| Net Chg. in Cash | -$35,026 | $25,052 | $9,250 | -$5,295 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $65,446 | $40,394 | $31,144 | $36,439 |
| End Cash | $30,420 | $65,446 | $40,394 | $31,144 |
| Free Cash Flow | -$106,194 | -$84,889 | -$42,222 | -$27,822 |